Biofil Chemicals And Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 20.00 Cr
- Paid Up Capital ₹ 16.27 Cr
- Company Age 40 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 14.00 Cr
- Revenue Growth 33.73%
- Profit Growth -19.76%
- Ebitda -12.39%
- Net Worth 2.76%
- Total Assets 67.66%
About Biofil Chemicals And Pharmaceuticals
Biofil Chemicals And Pharmaceuticals Limited (BCAPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 04 January 1985 and has a history of 40 years and one month. Its registered office is in Indore, Madhya Pradesh, India.
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 524396 and on the National Stock Exchange(NSE) under BIOFILCHEM.
The Corporate was formerly known as Biofil Chemicals And Pharmaceuticals Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 20.00 Cr and a paid-up capital of Rs 16.27 Cr.
The company has closed loans amounting to ₹14.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Biofil Chemicals And Pharmaceuticals Limited India are Pavan Rajput as CFO and Anisha Mangal as Company Secretary. Gayatri Padiyar, Satish Beohar, Ashok Ramawat, and Three other members serve as directors at the Company.
Company Details
- Location
Indore, Madhya Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
L24233MP1985PLC002709
- Company No.
002709
- Stock Symbol
BSE : 524396 NSE : BIOFILCHEM
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
04 Jan 1985
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Listed
- ROC Code
Roc Gwalior
Industry
What products or services does Biofil Chemicals And Pharmaceuticals Limited offer?
Biofil Chemicals And Pharmaceuticals Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Fitness Supplements, Gardening and Horticulture Tools, Garden Watering Tools, Industrial Chemicals & Supplies, Sewage Treatment Chemical, Packaging Caps & Seals, Cap Closures, Chemical Reagents & Catalysts, Ferrous Compounds.
Who are the key members and board of directors at Biofil Chemicals And Pharmaceuticals?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pavan Rajput | CFO | 14-Nov-2022 | Current |
| Anisha Mangal | Company Secretary | 03-Oct-2024 | Current |
Ramesh Shah  | Managing Director | 04-Jan-1985 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gayatri Padiyar | Director | 14-Aug-2023 | Current |
| Satish Beohar | Director | 30-Jun-2021 | Current |
| Ashok Ramawat | Director | 25-Aug-2020 | Current |
| Ketan Shah | Whole-Time Director | 25-Aug-2020 | Current |
| Romil Shah | Director | 30-Jul-2005 | Current |
Financial Performance of Biofil Chemicals And Pharmaceuticals.
Biofil Chemicals And Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 33.73% increase. The company also saw a substantial fall in profitability, with a 19.76% decrease in profit. The company's net worth moved up by a moderate rise of 2.76%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biofil Chemicals And Pharmaceuticals?
In 2022, Biofil Chemicals And Pharmaceuticals had a promoter holding of 46.82% and a public holding of 53.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mppmo Analytical And Research Centre Private LimitedAshok Ramawat is a mutual person
- Sanprabha Welfare Foundation
Ketan Shah and Ramesh Shah are mutual person
- Cyano It Services Private Limited
Romil Shah and Ramesh Shah are mutual person
- Formo Plast Pvt.Ltd.
Romil Shah is a mutual person
- Mid (India) Pharmaceuticals Pvt Ltd
Romil Shah is a mutual person
- Sedate Mercantile Private Limited
Romil Shah is a mutual person
Charges (Loans)
₹0
₹14.00 Cr
Charges Breakdown by Lending Institutions
- Industrial Development Bank Of India : 14.00 Cr
- Canara Bank : 0.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 1998 | Industrial Development Bank Of India | ₹4.00 Cr | Satisfied |
| 12 Jul 1996 | Canara Bank | ₹0.00 | Satisfied |
| 12 Sep 1995 | Industrial Development Bank Of India | ₹10.00 Cr | Satisfied |
| 13 Mar 1995 | Canara Bank | ₹0.00 | Satisfied |
| 13 Mar 1995 | Canara Bank | ₹0.00 | Satisfied |
How Many Employees Work at Biofil Chemicals And Pharmaceuticals?
Biofil Chemicals And Pharmaceuticals has a workforce of 19 employees as of Mar 23, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biofil Chemicals And Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biofil Chemicals And Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
